| Literature DB >> 26070963 |
Yi-Jun Chen1, Xiao Zhang2, Zheng-Sheng Wu3, Jing-Jing Wang1, Amy Yong-Chen Lau1, Tao Zhu4, Peter E Lobie5.
Abstract
The oncogenic effects of autocrine human growth hormone (hGH) have been intensively investigated in estrogen receptor-positive mammary carcinoma (ER + MC) cells. We demonstrated herein that autocrine hGH promoted cancer stem cell (CSC)-like properties of estrogen receptor-negative mammary carcinoma (ER-MC) cells in vitro. In xenograft studies, autocrine hGH increased the tumor initiating capacity of ER-MC cells. We also observed that autocrine hGH promoted migration and invasion of ER-MC cells in vitro, and metastasis in vivo. Thus, inhibition of hGH is a potential therapeutic strategy to prevent tumor initiation and metastasis of ER-MC.Entities:
Keywords: Cancer stem cell; Human growth hormone; Mammary carcinoma; Metastasis; Tumor initiation
Mesh:
Substances:
Year: 2015 PMID: 26070963 DOI: 10.1016/j.canlet.2015.05.031
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679